- After the hump: Pfizer-AstraZeneca combo on downhill slope
- US Capitol Capsule: Rare disease sector matures; FDA keeping pace?
- PROFILE: Mundipharma's Antony Mattessich on his journey from terror expert to pharma, contrarian-style
- PROFILE: AstraZeneca's Mene Pangalos on yin and yang, not believing your own press, and his part in Soriot's vision
ANALYSIS Other Informa Analysis
- PROFILE: Vas Narasimhan on many Novartis roles, extinction fears and Hilleman influences
- PROFILE: Antisense pioneer Stanley Crooke on injustice, the American dream, and letting go